Computational research · Methods
Methods and reproducibility
How each study was computed, which software and versions were used, and how the numerical tools were checked before use.
Open toolsAll calculations use open-source software. Inputs are published data with their sources; scripts and outputs are kept with each figure.
Standards
Six rules every figure follows
- Each figure is produced by a script from data files; the figure, its data (CSV) and a metadata record with caption, status, method, sources and limitations are written together.
- Force-field results are labeled as force-field results. No figure reports an empirical or force-field quantity as a quantum-chemical or COSMO-RS result.
- Monte Carlo propagation, Markov chain Monte Carlo and Bayesian optimization are separate methods and are named separately.
- Parent compound and conjugates are reported separately wherever a source reports both.
- Random seeds are fixed (20261105 unless stated), and software versions are recorded with each figure.
- Every figure passes an automated check for overlapping or clipped text before it is published.
Methods
Method, settings and script for each study
| Study | Method and settings | Script |
|---|---|---|
| Conformer search | RDKit ETKDGv3 (seed 20261105, no pruning) → MMFF94s minimization (5,000 iterations); uniqueness by 0.005 kcal/mol and 0.15 Å; Butina clustering at 1.0 Å. | 01_molecular_structures/s01_compute.py, s01_export_minima.py |
| Force field in OpenMM | MMFF94s implemented as custom forces with MMFF functional forms (buffered 14-7 van der Waals, buffered Coulomb), PME electrostatics; total energies agree with RDKit within 1.0e-04 kcal/mol for every molecule and a water dimer. | 02_force_fields_and_MD/mmff_openmm.py, verify_mmff.py |
| Molecular dynamics | One solute in a cubic water (2.7 nm) or ethanol (3.0 nm) box; Langevin 300 K, Monte Carlo barostat 1 bar, 2 fs with hydrogen constraints; 20 ps equilibration, then 60 ps production for each of two curcumin replicates and 40 ps for quercetin and for berberine chloride. | 02_force_fields_and_MD/md_run.py |
| Solubility data | BigSolDB 2.0 (103,944 measurements; SHA-256 recorded); van 't Hoff fits per solvent and source; ideal solubility bounded by Walden's rule and the Joback estimate. | 03_thermodynamics_CAMD/thermo_compute.py |
| QSPR model | Histogram gradient boosting on RDKit descriptors and Morgan count fingerprints; every measurement of a solute held out together (GroupKFold, 5 folds). | 03_thermodynamics_CAMD/thermo_compute.py |
| Extraction model | Crank's solution for diffusion from spheres into a stirred solution of limited volume, transformed time for variable temperature, Arrhenius degradation; a port of the process-engineering page model, checked against it to machine precision. | 04_extraction_and_process/extract_model.py |
| Pharmacokinetics | One-compartment Bateman models calibrated to published summary statistics with PyMC (NUTS, 4 chains × 2,000 draws, target acceptance 0.97); R-hat ≤ 1.003, bulk ESS ≥ 1,263, no divergences. | 06_PK_PBPK/pk_data.py, pk_fit.py |
| MCMC demonstration | Random-walk Metropolis on published degradation rate constants; four chains from dispersed starts; Gelman–Rubin R-hat. | 07_MCMC_uncertainty/mc_figs.py |
| Optimization | Gaussian-process regression (Matérn 5/2, ARD) with expected improvement; Monte Carlo robust fronts; probabilistic design space. | 08_multiobjective_optimization/opt_figs.py |
| Flow benchmark | Lid-driven cavity at Re = 100, stream function–vorticity; centerline u within 0.0043 of Ghia et al. (1982) on 129 × 129; observed order about 2. | 09_validation_benchmarks/cavity.py |
Software
Software versions recorded with the figures
| Package | Version |
|---|---|
| python | 3.13.16 |
| numpy | 2.5.3 |
| scipy | 1.18.1 |
| pandas | 3.0.5 |
| matplotlib | 3.11.2 |
| rdkit | 2026.09.1 |
| openmm | 8.6.1 |
| pymc | 6.4.0 |
| arviz | 1.3.0 |
| sklearn | 1.9.1 |
| thermo | 0.6.1 |
Sources
Data sources and code cited by the figures
- 11 ng/mL at pH 5 (Brotons-Canto et al. Pharmaceutics 2021;13:361, quoting Tønnesen et al. 2002); 1–10 µg/mL estimated at neutral pH (Nelson et al. J Med Chem 2017); 1.78 ± 0.17 µg/mL in water at 37 °C (Guo et al. 2026); berberine hydrochloride 0.162 mg/mL at pH 1.2 to 2.78 mg/mL at pH 6.8, 37 °C (Chen et al. 2024). ICH M9 (2019) Biopharmaceutics Classification System-based biowaivers. Script 05_delivery_QbD/form_figs.py; transcriptions in form_data.py; source XML in 00_provenance/literature.
- Chen X et al. Self-microemulsifying drug delivery system to enhance oral bioavailability of berberine hydrochloride in rats. Pharmaceutics 2024;16(9):1116. doi:10.3390/pharmaceutics16091116. PMID 39339154, PMC11435259 Li J et al. Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine. J Nanobiotechnology 2018;16:76. doi:10.1186/s12951-018-0402-x. PMID 30290822, PMC6172716 Guo et al. Formulation development and characterization of quercetin solid dispersions with integrated in vitro release and in vivo pharmacokinetic assessment. Pharmaceuticals 2026;19(10):1625. doi:10.3390/ph19101625. PMID 42943322, PMC13708282 Human berberine: DDDT 2019;13:129 (FIG 032). Script 05_delivery_QbD/form_figs.py; transcriptions in form_data.py; source XML in 00_provenance/literature.
- Chen X et al. Self-microemulsifying drug delivery system to enhance oral bioavailability of berberine hydrochloride in rats. Pharmaceutics 2024;16(9):1116. doi:10.3390/pharmaceutics16091116. PMID 39339154, PMC11435259 Li J et al. Self-nanoemulsifying system improves oral absorption and enhances anti-acute myeloid leukemia activity of berberine. J Nanobiotechnology 2018;16:76. doi:10.1186/s12951-018-0402-x. PMID 30290822, PMC6172716 Script 05_delivery_QbD/form_figs.py; transcriptions in form_data.py; source XML in 00_provenance/literature.
- Chen X et al. Self-microemulsifying drug delivery system to enhance oral bioavailability of berberine hydrochloride in rats. Pharmaceutics 2024;16(9):1116. doi:10.3390/pharmaceutics16091116. PMID 39339154, PMC11435259 Script 05_delivery_QbD/form_figs.py; transcriptions in form_data.py; source XML in 00_provenance/literature.
- Curcumin: Bernabé-Pineda M et al. Spectrochim Acta A 2004;60:1091–1097, doi:10.1016/S1386-1425(03)00342-1. Quercetin: Berga M et al. Pharmaceuticals 2023;16(10):1407, Table A1, doi:10.3390/ph16101407. pH range: ICH M9 (2019) biopharmaceutics classification, solubility over pH 1.2–6.8. Script 01_molecular_structures/s01_figures.py.
- Data: Li G, Zhao M, Qiu F, Sun Y, Zhao L. Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects. Drug Des Devel Ther 2019;13:129–139. doi:10.2147/DDDT.S185487 (berberine 300 mg single dose, n = 12, Table 6).
- Data: Li G, Zhao M, Qiu F, Sun Y, Zhao L. Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects. Drug Des Devel Ther 2019;13:129–139. doi:10.2147/DDDT.S185487 (berberine 300 mg single dose, n = 12, Table 6).; Data: Graefe et al., J Clin Pharmacol 2001;41:492–499 (n = 12 crossover).
- Data: Li G, Zhao M, Qiu F, Sun Y, Zhao L. Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects. Drug Des Devel Ther 2019;13:129–139. doi:10.2147/DDDT.S185487 (berberine 300 mg single dose, n = 12, Table 6).; Data: Graefe et al., J Clin Pharmacol 2001;41:492–499 (n = 12 crossover).; Data: Vareed et al., Cancer Epidemiol Biomarkers Prev 2008;17:1411–1417; iScience 2025;28:112575.
- Data: Graefe et al., J Clin Pharmacol 2001;41:492–499 (n = 12 crossover).
- Data: Vareed et al., Cancer Epidemiol Biomarkers Prev 2008;17:1411–1417; iScience 2025;28:112575.; Data: Graefe et al., J Clin Pharmacol 2001;41:492–499 (n = 12 crossover).; Data: Li G, Zhao M, Qiu F, Sun Y, Zhao L. Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects. Drug Des Devel Ther 2019;13:129–139. doi:10.2147/DDDT.S185487 (berberine 300 mg single dose, n = 12, Table 6).
- Dechayont B, Brunaugh AD. Chitosan stabilizes curcumin against hydrolysis and potentiates antimicrobial activity against Pseudomonas aeruginosa in a pH-dependent manner. ACS Omega 2026;11(31):46088–46104. doi:10.1021/acsomega.6c02415. PMID 42597930, PMC13470882 Script 05_delivery_QbD/form_figs.py; transcriptions in form_data.py; source XML in 00_provenance/literature.
- Dechayont B, Brunaugh AD. Chitosan stabilizes curcumin against hydrolysis and potentiates antimicrobial activity against Pseudomonas aeruginosa in a pH-dependent manner. ACS Omega 2026;11(31):46088–46104. doi:10.1021/acsomega.6c02415. PMID 42597930, PMC13470882 Script 07_MCMC_uncertainty/mc_figs.py.
- Dechayont B, Brunaugh AD. Chitosan stabilizes curcumin against hydrolysis and potentiates antimicrobial activity against Pseudomonas aeruginosa in a pH-dependent manner. ACS Omega 2026;11(31):46088–46104. doi:10.1021/acsomega.6c02415. PMID 42597930, PMC13470882 Wang YJ et al. Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 1997;15(12):1867-76. PMID 9278892 Script 05_delivery_QbD/form_figs.py; transcriptions in form_data.py; source XML in 00_provenance/literature.
- Li G, Zhao M, Qiu F, Sun Y, Zhao L. Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects. Drug Des Devel Ther 2019;13:129–139. doi:10.2147/DDDT.S185487 (berberine 300 mg single dose, n = 12, Table 6). Scripts 06_PK_PBPK/pk_fit.py and 07_MCMC_uncertainty/mc_figs.py.
- EUTECNIQ process-engineering page, illustrative 1,000 kg batch (src/modules/process/mod.js, MS_LINKS; equipment tags as on the page). Script 04_extraction_and_process/process_figs.py.
- EUTECNIQ process-engineering page, illustrative mass balance (src/modules/process/mod.js, MS_LINKS). Script 04_extraction_and_process/extract_figs.py.
- Ghia U, Ghia KN, Shin CT. J Comput Phys 1982;48(3):387–411, Table I (u-velocity, Re = 100), as transcribed in a public gist (github.com/ivan-pi). Scripts 09_validation_benchmarks/cavity.py and bench_figs.py.
- Guo et al. Formulation development and characterization of quercetin solid dispersions with integrated in vitro release and in vivo pharmacokinetic assessment. Pharmaceuticals 2026;19(10):1625. doi:10.3390/ph19101625. PMID 42943322, PMC13708282 Script 05_delivery_QbD/form_figs.py; transcriptions in form_data.py; source XML in 00_provenance/literature.
- ICH Q8(R2) Pharmaceutical Development (2009); ICH Q9(R1) Quality Risk Management (2023). Data sources as in FIG 021–023. Script 04_extraction_and_process/process_figs.py.
- Illustrative extraction simulator of FIG 016 (Crank eq. 6.30 with Arrhenius diffusion and degradation; Python port of the EUTECNIQ process-engineering page model). Script 08_multiobjective_optimization/opt_figs.py.
- Illustrative extraction simulator of FIG 016 (Crank eq. 6.30 with Arrhenius diffusion and degradation; Python port of the EUTECNIQ process-engineering page model). Script 08_multiobjective_optimization/opt_figs.py. ICH Q8(R2) Pharmaceutical Development (2009), definition of design space.
- Krasnov L. et al. BigSolDB 2.0, Zenodo (CSV v2.0; SHA256 879f55f3…). Curcumin rows: Cui et al. J Mol Liq 2021 (10.1016/j.molliq.2021.116795); Shen et al. J Chem Thermodyn 2019 (10.1016/j.jct.2018.11.022); Fluid Phase Equilib 2021 (10.1016/j.fluid.2020.112917). Quercetin rows: Razmara et al. J Chem Eng Data 2010 (10.1021/je9010757); Zhang et al. J Mol Liq 2017 (10.1016/j.molliq.2016.11.036); Montenegro et al. J Chem Thermodyn 2025;203:107434 (10.1016/j.jct.2024.107434). Hansen CM. Hansen Solubility Parameters: A User's Handbook, 2nd ed. CRC Press, 2007; n-hexane: Carré et al. 2024. Berga M et al. Pharmaceuticals 2023;16(10):1407, Table A3 (group-contribution estimate), doi:10.3390/ph16101407 Scripts 03_thermodynamics_CAMD/thermo_compute.py and thermo_figs.py.
- Krasnov L. et al. BigSolDB 2.0, Zenodo (CSV v2.0; SHA256 879f55f3…). Curcumin rows: Cui et al. J Mol Liq 2021 (10.1016/j.molliq.2021.116795); Shen et al. J Chem Thermodyn 2019 (10.1016/j.jct.2018.11.022); Fluid Phase Equilib 2021 (10.1016/j.fluid.2020.112917). Quercetin rows: Razmara et al. J Chem Eng Data 2010 (10.1021/je9010757); Zhang et al. J Mol Liq 2017 (10.1016/j.molliq.2016.11.036); Montenegro et al. J Chem Thermodyn 2025;203:107434 (10.1016/j.jct.2024.107434). ICH Q3C(R8) Impurities: Guideline for Residual Solvents, Step 4, April 22, 2021, Tables 2 and 3 (database.ich.org). Enthalpies and boiling points from thermo 0.6.1 / chemicals 1.5.2. Scripts 03_thermodynamics_CAMD/thermo_compute.py and thermo_figs.py.
- Krasnov L. et al. BigSolDB 2.0, Zenodo (CSV v2.0; SHA256 879f55f3…). Curcumin rows: Cui et al. J Mol Liq 2021 (10.1016/j.molliq.2021.116795); Shen et al. J Chem Thermodyn 2019 (10.1016/j.jct.2018.11.022); Fluid Phase Equilib 2021 (10.1016/j.fluid.2020.112917). Quercetin rows: Razmara et al. J Chem Eng Data 2010 (10.1021/je9010757); Zhang et al. J Mol Liq 2017 (10.1016/j.molliq.2016.11.036); Montenegro et al. J Chem Thermodyn 2025;203:107434 (10.1016/j.jct.2024.107434). Independent 37 °C quercetin value: Guo et al. Pharmaceuticals 2026;19(10):1625, doi:10.3390/ph19101625. Scripts 03_thermodynamics_CAMD/thermo_compute.py and thermo_figs.py.
- Krasnov L. et al. BigSolDB 2.0, Zenodo (CSV v2.0; SHA256 879f55f3…). Curcumin rows: Cui et al. J Mol Liq 2021 (10.1016/j.molliq.2021.116795); Shen et al. J Chem Thermodyn 2019 (10.1016/j.jct.2018.11.022); Fluid Phase Equilib 2021 (10.1016/j.fluid.2020.112917). Quercetin rows: Razmara et al. J Chem Eng Data 2010 (10.1021/je9010757); Zhang et al. J Mol Liq 2017 (10.1016/j.molliq.2016.11.036); Montenegro et al. J Chem Thermodyn 2025;203:107434 (10.1016/j.jct.2024.107434). Scripts 03_thermodynamics_CAMD/thermo_compute.py and thermo_figs.py.
- Krasnov L. et al. BigSolDB 2.0, Zenodo (CSV v2.0; SHA256 879f55f3…). Curcumin rows: Cui et al. J Mol Liq 2021 (10.1016/j.molliq.2021.116795); Shen et al. J Chem Thermodyn 2019 (10.1016/j.jct.2018.11.022); Fluid Phase Equilib 2021 (10.1016/j.fluid.2020.112917). Quercetin rows: Razmara et al. J Chem Eng Data 2010 (10.1021/je9010757); Zhang et al. J Mol Liq 2017 (10.1016/j.molliq.2016.11.036); Montenegro et al. J Chem Thermodyn 2025;203:107434 (10.1016/j.jct.2024.107434). Tm: 183 °C, HSDB via PubChem (CRC: 456.15 K). Joback estimate via the chemicals 1.5.2 library. Scripts 03_thermodynamics_CAMD/thermo_compute.py and thermo_figs.py.
- MMFF94s in OpenMM 8.6.1 (custom forces verified against RDKit), PME, Langevin 300 K, Monte Carlo barostat 1 bar, 2 fs; frames every 0.5 ps. Scripts 02_force_fields_and_MD/md_run.py and md_figs.py.
- MMFF94s in OpenMM 8.6.1 (custom forces verified against RDKit), PME, Langevin 300 K, Monte Carlo barostat 1 bar, 2 fs; frames every 0.5 ps. Scripts 02_force_fields_and_MD/md_run.py and md_figs.py. Verification: 02_force_fields_and_MD/verify_mmff.py.
- Deduplicate the list to one entry per source (Bernabé-Pineda 2004; Berga 2023; Krasnov BigSolDB 2.0 and its row sources; Hansen 2007; Chen 2024; Li 2018; Guo 2026; Dechayont 2026; Wang 1997; Li G 2019 DDDT; Graefe 2001; Vareed 2008; Kroon 2025; Ghia 1982; Crank 1975; ICH M9, Q3C(R8), Q8(R2), Q9(R1); Rothwell 2005) and remove 'Model calibrated in FIG 032–035.' and 'PK fits, this study.'
- PK fits, this study.
- Published composition: Chen X et al. Self-microemulsifying drug delivery system to enhance oral bioavailability of berberine hydrochloride in rats. Pharmaceutics 2024;16(9):1116. doi:10.3390/pharmaceutics16091116. PMID 39339154, PMC11435259 Bounds are analyst assumptions. Script 05_delivery_QbD/form_figs.py; transcriptions in form_data.py; source XML in 00_provenance/literature.
- Python port of the EUTECNIQ process-engineering page model (src/modules/process/mod.js), verified to reproduce the page's JavaScript output to machine precision for the default case. Crank J. The Mathematics of Diffusion, 2nd ed., Oxford 1975, eq. 6.30 and sec. 7.2. Scripts 04_extraction_and_process/extract_model.py and extract_figs.py.
- RDKit 2026.09.1 ETKDGv3 embedding (seed 20261105, no pruning) and MMFF94s minimization (maxIters 5000); scripts 01_molecular_structures/s01_compute.py and s01_export_minima.py. Structures from PubChem (CIDs 969516, 5280343, 2353).
- RDKit 2026.09.1 ETKDGv3 embedding (seed 20261105, no pruning) and MMFF94s minimization (maxIters 5000); scripts 01_molecular_structures/s01_compute.py and s01_export_minima.py. Structures from PubChem (CIDs 969516, 5280343, 2353). Earlier 100-start run (version 0 of this calculation): conformer table kept in 00_provenance/.
- RDKit 2026.09.1 ETKDGv3 embedding (seed 20261105, no pruning) and MMFF94s minimization (maxIters 5000); scripts 01_molecular_structures/s01_compute.py and s01_export_minima.py. Structures from PubChem (CIDs 969516, 5280343, 2353). Experimental quercetin log P: PubChem (Sangster) and Rothwell JA et al. J Agric Food Chem 2005.
- Simulated data (seed 20261105) generated to demonstrate the method; no EUTECNIQ batch, instrument or operator data exist yet. Script 09_validation_benchmarks/bench_figs.py.
- Sources as cited in FIG 011–045 and their metadata files. Script 05_delivery_QbD/form_figs.py; transcriptions in form_data.py; source XML in 00_provenance/literature.
- Kroon MAGM, van Laarhoven HWM, Swart EL, van Tellingen O, Kemper EM. A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability. Kroon MAGM et al. A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability. Kroon MAGM et al. A pharmacokinetic study and critical reappraisal of curcumin formulations enhancing bioavailability. iScience 2025;28(6):112575, Table 2. doi:10.1016/j.isci.2025.112575
Health information notice. These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease, and nothing here is medical advice.
Read the full notice
The information is for general education only. It does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed. Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.